» Articles » PMID: 24024497

The Effects of Airway Microbiome on Corticosteroid Responsiveness in Asthma

Overview
Specialty Critical Care
Date 2013 Sep 13
PMID 24024497
Citations 180
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: The role of airway microbiome in corticosteroid response in asthma is unknown.

Objectives: To examine airway microbiome composition in patients with corticosteroid-resistant (CR) asthma and compare it with patients with corticosteroid-sensitive (CS) asthma and normal control subjects and explore whether bacteria in the airways of subjects with asthma may direct alterations in cellular responses to corticosteroids.

Methods: 16S rRNA gene sequencing was performed on bronchoalveolar lavage (BAL) samples of 39 subjects with asthma and 12 healthy control subjects. In subjects with asthma, corticosteroid responsiveness was characterized, BAL macrophages were stimulated with pathogenic versus commensal microorganisms, and analyzed by real-time polymerase chain reaction for the expression of corticosteroid-regulated genes and cellular p38 mitogen-activated protein kinase (MAPK) activation.

Measurements And Main Results: Of the 39 subjects with asthma, 29 were CR and 10 were CS. BAL microbiome from subjects with CR and CS asthma did not differ in richness, evenness, diversity, and community composition at the phylum level, but did differ at the genus level, with distinct genus expansions in 14 subjects with CR asthma. Preincubation of asthmatic airway macrophages with Haemophilus parainfluenzae, a uniquely expanded potential pathogen found only in CR asthma airways, resulted in p38 MAPK activation, increased IL-8 (P < 0.01), mitogen-activated kinase phosphatase 1 mRNA (P < 0.01) expression, and inhibition of corticosteroid responses (P < 0.05). This was not observed after exposure to commensal bacterium Prevotella melaninogenica. Inhibition of transforming growth factor-β-associated kinase-1 (TAK1), upstream activator of MAPK, but not p38 MAPK restored cellular sensitivity to corticosteroids.

Conclusions: A subset of subjects with CR asthma demonstrates airway expansion of specific gram-negative bacteria, which trigger TAK1/MAPK activation and induce corticosteroid resistance. TAK1 inhibition restored cellular sensitivity to corticosteroids.

Citing Articles

T1-T2 Interplay in the Complex Immune Landscape of Severe Asthma.

Gauthier M, Kale S, Ray A Immunol Rev. 2025; 330(1):e70011.

PMID: 39991821 PMC: 11849004. DOI: 10.1111/imr.70011.


Linking Microbiota Profiles to Disease Characterization in Common Variable Immunodeficiency: The Case of Granulomatous-Lymphocytic Interstitial Lung Disease.

Cabanero-Navalon M, Carda-Dieguez M, Moral Moral P, Mira A, Balastegui-Martin H, Salavert-Lleti M Biomedicines. 2024; 12(10).

PMID: 39457552 PMC: 11505043. DOI: 10.3390/biomedicines12102239.


Impact of the Lung Microbiota on Development and Progression of Lung Cancer.

Belaid A, Romeo B, Rignol G, Benzaquen J, Audoin T, Vouret-Craviari V Cancers (Basel). 2024; 16(19).

PMID: 39409962 PMC: 11605235. DOI: 10.3390/cancers16193342.


Sex-specific alterations in the gut and lung microbiome of allergen-induced mice.

Ekpruke C, Alford R, Rousselle D, Babayev M, Sharma S, Parker E Front Allergy. 2024; 5:1451846.

PMID: 39210977 PMC: 11358121. DOI: 10.3389/falgy.2024.1451846.


The effects of different lung parts, age, and batches on the lung microbiota of healthy rats.

Chen P, Hu T, Jiang H, Li B, Li G, Ran P Ann Med. 2024; 56(1):2381085.

PMID: 39099020 PMC: 11299442. DOI: 10.1080/07853890.2024.2381085.


References
1.
Komaniecka I, Choma A, Lindner B, Holst O . The structure of a novel neutral lipid A from the lipopolysaccharide of Bradyrhizobium elkanii containing three mannose units in the backbone. Chemistry. 2010; 16(9):2922-9. DOI: 10.1002/chem.200902390. View

2.
Erb-Downward J, Thompson D, Han M, Freeman C, McCloskey L, Schmidt L . Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011; 6(2):e16384. PMC: 3043049. DOI: 10.1371/journal.pone.0016384. View

3.
Walsh G, Sexton D, Blaylock M . Corticosteroids, eosinophils and bronchial epithelial cells: new insights into the resolution of inflammation in asthma. J Endocrinol. 2003; 178(1):37-43. DOI: 10.1677/joe.0.1780037. View

4.
Busse W, Wanner A, Adams K, Reynolds H, Castro M, Chowdhury B . Investigative bronchoprovocation and bronchoscopy in airway diseases. Am J Respir Crit Care Med. 2005; 172(7):807-16. PMC: 2718402. DOI: 10.1164/rccm.200407-966WS. View

5.
Goleva E, Hauk P, Boguniewicz J, Martin R, Leung D . Airway remodeling and lack of bronchodilator response in steroid-resistant asthma. J Allergy Clin Immunol. 2007; 120(5):1065-72. PMC: 2697657. DOI: 10.1016/j.jaci.2007.07.042. View